Comparison 8. Laser plus sclerotherapy (polidocanol) versus sclerotherapy (polidocanol).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
8.1 Resolution or improvement of telangiectasias	2	710	Std. Mean Difference (IV, Random, 95% CI)	5.68 [5.14, 6.23]
8.2 Adverse events	2		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
8.2.1 Hyperpigmentation	2	656	Risk Ratio (M‐H, Random, 95% CI)	0.83 [0.35, 1.99]
8.2.2 Matting	2	656	Risk Ratio (M‐H, Random, 95% CI)	0.83 [0.21, 3.28]
8.3 Pain	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected